Document
IPR2017-01035, No. 1023-17 Exhibit - MYLAN Ex 1023 US Patent No 5,342,625 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1023-17 Exhibit - MYLAN Ex 1023 US Patent No 5,342,625 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1002-2 Exhibit - MYLAN Ex 1002 US Patent No 8,784,888 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1002-2 Exhibit - MYLAN Ex 1002 US Patent No 8,784,888 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1039-30 Exhibit - MYLAN Ex 1039 SS Davis, STP Pharma 1987 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1039-30 Exhibit - MYLAN Ex 1039 SS Davis, STP Pharma 1987 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1036-27 Exhibit - MYLAN Ex 1036 Gandhi et al, (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1036-27 Exhibit - MYLAN Ex 1036 Gandhi et al, (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1052-43 Exhibit - MYLAN Ex 1052 Amendment filed on January 15, 2013 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1052-43 Exhibit - MYLAN Ex 1052 Amendment filed on January 15, 2013 in US Patent Appl No 13617,138 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1035-26 Exhibit - MYLAN Ex 1035 Flanders et al, (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1035-26 Exhibit - MYLAN Ex 1035 Flanders et al, (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1058-49 Exhibit - MYLAN Ex 1058 Applicant Initiated Interview Summary of April 23, 2013 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1058-49 Exhibit - MYLAN Ex 1058 Applicant Initiated Interview Summary of April 23, 2013 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1010-7 Exhibit - MYLAN Ex 1010 US Patent No 6,239,120 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1010-7 Exhibit - MYLAN Ex 1010 US Patent No 6,239,120 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1022-16 Exhibit - MYLAN Ex 1022 PCT International Publication No WO 9636318 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1022-16 Exhibit - MYLAN Ex 1022 PCT International Publication No WO 9636318 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1011-8 Exhibit - MYLAN Ex 1011 US Patent Appl Pub No 20060134208 (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1011-8 Exhibit - MYLAN Ex 1011 US Patent Appl Pub No 20060134208 (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1025-19 Exhibit - MYLAN Ex 1025 FDA Inactive Ingredient Guide (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1025-19 Exhibit - MYLAN Ex 1025 FDA Inactive Ingredient Guide (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 1050-41 Exhibit - MYLAN Ex 1050 Transcript of the Second Quarter 2014 Earnings Conf Call (P.T.A.B. Mar. 9, 2017)
Cite Document
IPR2017-01035, No. 1050-41 Exhibit - MYLAN Ex 1050 Transcript of the Second Quarter 2014 Earnings Conf Call (P.T.A.B. Mar. 9, 2017)
+ More Snippets
Document
IPR2017-01035, No. 2012-65 Exhibit - Ex 2012 Amendment and Response to Advisory Action (P.T.A.B. Jun. 22, 2017)
Cite Document
IPR2017-01035, No. 2012-65 Exhibit - Ex 2012 Amendment and Response to Advisory Action (P.T.A.B. Jun. 22, 2017)
+ More Snippets
Document
IPR2017-01035, No. 2018-71 Exhibit - Ex 2018 Aulton 1988 (P.T.A.B. Jun. 22, 2017)
Cite Document
IPR2017-01035, No. 2018-71 Exhibit - Ex 2018 Aulton 1988 (P.T.A.B. Jun. 22, 2017)
+ More Snippets
Document
IPR2017-01035, No. 2030-83 Exhibit - Ex 2030 Nicholls 2013 (P.T.A.B. Jun. 22, 2017)
Cite Document
IPR2017-01035, No. 2030-83 Exhibit - Ex 2030 Nicholls 2013 (P.T.A.B. Jun. 22, 2017)
+ More Snippets